- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Hikal Limited — Updates, 11-02-2026: Press Release
11-02-2026 | 05:00 pm
11-02-2026 | 05:00 pm
Hikal reported Q3 revenue of ₹494 Cr (+10% YoY) and EBITDA of ₹83 Cr (+15% YoY). Pharma business saw strong recovery, while Crop Protection grew. Remediation measures are largely complete, improving capacity utilization. Board approved 10% interim dividend.
No comments yet. Be the first to comment!